Mareike Roth
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- Acute Myeloid Leukemia Research 8
-
- Protein Degradation and Inhibitors 5
- Histone Deacetylase Inhibitors Research 3
- Retinoids in leukemia and cellular processes 2
- Ubiquitin and proteasome pathways 2
- Advanced biosensing and bioanalysis techniques 1
- Co-authors
- Johannes Zuber (13 shared papers)Inês Amorim Monteiro Barbosa (2 shared papers)Matthias Muhar (2 shared papers)Barbara Hopfgartner (1 shared paper)Christof Fellmann (1 shared paper)Thomas Hoffmann (3 shared papers)Barbara Werner (2 shared papers)Meinrad Busslinger (2 shared papers)
- Journals
- Blood (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Nature Communications (1 paper)Cell Reports (1 paper)Frontiers in Neuroscience (1 paper)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Mareike Roth
16 papers receiving 902 citations
Peers
Comparison fields: 5 of 73
- Hematology 190
- Cancer Research 160
- Molecular Biology 637
- Immunology 146
- Oncology 149
Countries citing papers authored by Mareike Roth
This map shows the geographic impact of Mareike Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mareike Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mareike Roth more than expected).
Fields of papers citing papers by Mareike Roth
This network shows the impact of papers produced by Mareike Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mareike Roth. The network helps show where Mareike Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Mareike Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 443 | |
| 2 | 2014 | 158 | |
| 3 | 2017 | 60 | |
| 4 | 2015 | 50 | |
| 5 | 2015 | 46 | |
| 6 | 2018 | 43 | |
| 7 | 2017 | 31 | |
| 8 | 1994 | 27 | |
| 9 | 2013 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2022 | 5 | |
| 12 | 2016 | 5 | |
| 13 | 2022 | 2 | |
| 14 | 2014 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2022 | 1 |
About Mareike Roth
Mareike Roth is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Cancer Research and Genetics, having authored 16 papers that have together received 909 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (5 papers), Histone Deacetylase Inhibitors Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Retinoids in leukemia and cellular processes (2 papers), Ubiquitin and proteasome pathways (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Hematology (190 citations), Cancer Research (160 citations), Molecular Biology (637 citations), Immunology (146 citations) and Oncology (149 citations). Mareike Roth has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Johannes Zuber, Inês Amorim Monteiro Barbosa, Matthias Muhar, Barbara Hopfgartner, Christof Fellmann, Thomas Hoffmann, Barbara Werner, Meinrad Busslinger, Markus Jaritz and Ross A. Dickins. Their work appears in journals such as Blood, Journal of Pharmacology and Experimental Therapeutics, Nature Communications, Cell Reports and Frontiers in Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.